Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel
骨生物标志物与激素敏感性前列腺癌患者的后续生存率:来自SWOG S1216 III期临床试验的结果,该试验比较了使用或不使用奥特罗内尔的雄激素剥夺疗法。
期刊:
影响因子:
doi:10.1016/j.eururo.2023.03.036
Lara, Primo N Jr; Mayerson, Edward; Gertz, Erik; Tangen, Catherine; Goldkorn, Amir; van Loan, Marta; Hussain, Maha; Gupta, Shilpa; Zhang, Jingsong; Parikh, Mamta; Twardowski, Przemyslaw; Quinn, David I; LeBlanc, Michael; Vogelzang, Nicholas J; Thompson, Ian; Agarwal, Neeraj